Unifiram (DM-232) is a synthetic compound extensively used in neuropharmacological research due to its remarkable nootropic properties. Although it is structurally distinct from racetams, it shares several functional similarities and is being studied for its potential to enhance memory, cognition, and synaptic plasticity. Researchers value Unifiram’s effectiveness at extremely low doses, making it a leading candidate in studies involving neuroenhancement, learning models, and amnesia reversal.

• Memory Enhancement Research
  Unifiram is widely studied for its ability to improve memory retention in animal models. It is often tested in tasks like the passive avoidance test, where it has demonstrated superior performance compared to traditional nootropics.

• Cognitive Function Investigation
  The compound enhances higher cognitive processes such as learning, attention, and working memory. It is used to assess how modulation of excitatory neurotransmission affects cognition.

• Amnesia Reversal Studies
  Unifiram has shown the ability to reverse pharmacologically induced memory impairments, such as those caused by scopolamine or NBQX. This makes it valuable in modeling neurodegenerative conditions.

• Cholinergic System Modulation
  It is often studied in relation to the cholinergic system due to its capacity to increase acetylcholine release in the brain, especially in the cortex and hippocampus.

• Glutamatergic Modulation
  Researchers are examining how Unifiram indirectly potentiates AMPA receptors, contributing to faster synaptic signaling and increased plasticity.

• Neuroprotection Studies
  Some studies explore Unifiram for its protective effects against neurotoxicity and oxidative stress, particularly in preclinical models of aging and neurodegeneration.

• Synergistic Research with AMPAkines and Racetams
  Due to its AMPA receptor activity, Unifiram is often tested in combination with other nootropic agents to examine synergistic or complementary effects.

Unifiram does not bind directly to AMPA receptors but exerts its action through downstream modulation that enhances glutamatergic and cholinergic neurotransmission. Its mechanism of action is unique compared to classical racetams, which adds to its significance in experimental pharmacology.

• AMPA Receptor Potentiation
  Unifiram enhances excitatory neurotransmission by indirectly increasing the activity of AMPA-type glutamate receptors, which are crucial for synaptic plasticity and fast synaptic transmission.

• Cholinergic Enhancement
  It stimulates the release of acetylcholine, a neurotransmitter essential for attention and memory. This cholinergic activation is observed in regions associated with learning such as the hippocampus.

• Signal Transduction Pathway Modulation
  Unifiram may activate intracellular pathways like protein kinase C (PKC) and CaMKII, which contribute to long-term potentiation (LTP) and memory consolidation.

• Synaptic Plasticity Support
  Through AMPA modulation and enhanced cholinergic signaling, Unifiram facilitates the formation and strengthening of synaptic connections, an essential component of learning.

• Low-Dose Efficacy
  One of its defining features is its effectiveness at nanomolar concentrations, which allows researchers to study potent effects with minimal pharmacological interference.

• No Direct Binding to Receptors
  Unifiram does not directly bind to glutamate or acetylcholine receptors, suggesting that its effects may involve modulation of endogenous neurotransmitter systems.

• Neurochemical Interaction Studies
  The compound is often used to explore the interactions between glutamatergic and cholinergic systems, two major pathways involved in cognition.

Unifiram is one of the most potent nootropic compounds known in the research community, with studies showing that it is approximately 1,000 to 10,000 times more potent than Piracetam. This allows researchers to study cognitive modulation at extremely low doses with minimal physiological disruption.

• Dosing Comparison
  While Piracetam is typically administered at 400–4,800 mg/kg in animal models, Unifiram is effective at 0.01–0.1 mg/kg, underscoring its nanomolar-level potency.

• Mechanistic Efficiency
  Despite its potency, Unifiram exerts its effects without direct receptor binding, suggesting a more refined and targeted mechanism of action.

• Behavioral Impact
  In comparative studies using tasks like step-down avoidance or radial arm maze, Unifiram consistently outperforms Piracetam in memory enhancement and learning speed.

• Less Risk of Side Effects
  Due to its low required dose, Unifiram may present fewer peripheral or off-target effects compared to high-dose racetams, making it suitable for precision research.

• Pharmacodynamic Profile
  The compound exhibits a rapid onset of action in animal models, with lasting cognitive effects observed well beyond administration.

• Structural Differences
  While structurally unrelated to Piracetam, Unifiram’s functional profile suggests overlapping targets, albeit through more potent modulation.

Unifiram is effective in animal studies at extremely low doses, generally ranging between 0.01 mg/kg and 0.1 mg/kg. This small dosing range is sufficient to produce significant cognitive and neurochemical effects in rodents without inducing toxicity or motor impairment.

• Typical Dose Range
  Most preclinical studies use doses between 0.03–0.1 mg/kg in rats or mice. These doses consistently yield enhancements in memory and learning performance.

• Dosing Route
  Intraperitoneal (i.p.) administration is most commonly used in research, although oral and intravenous routes have also been investigated with variable absorption.

• Frequency
  Acute single-dose studies are standard, but some models also explore chronic dosing over several days to study long-term plasticity.

• Dose-Response Relationship
  Unifiram demonstrates a bell-shaped dose-response curve, where higher doses may result in diminished efficacy, emphasizing the importance of precision.

• Comparative Studies
  When compared to racetams or AMPAkines, Unifiram requires significantly lower concentrations to produce similar or superior results.

• Observed Effects
  At standard doses, Unifiram improves performance in avoidance learning, recognition memory, and object location tests without sedation or hyperactivity.

Unifiram is strictly intended for laboratory research use and has not been approved for human consumption. There are no clinical trials, toxicity studies, or regulatory approvals supporting its use outside of controlled research environments. It should never be used in humans under any circumstance.

• Lack of Human Trials
  No peer-reviewed studies have evaluated Unifiram’s pharmacokinetics, safety, or efficacy in humans. All findings are based on animal models.

• Regulatory Classification
  Unifiram is not scheduled in most jurisdictions but is also not approved by the FDA, EMA, or any regulatory body for therapeutic or recreational use.

• Toxicity Unknown in Humans
  Long-term toxicity, potential side effects, or interactions with other substances in humans remain completely unknown.

• Not for Diagnostic or Therapeutic Use
  RC Plug supplies Unifiram strictly for in vitro or in vivo laboratory experiments conducted by qualified institutions.

• Animal Safety Profile
  In preclinical studies, Unifiram has not shown motor impairment, sedation, or gross toxicity at tested doses, which supports its suitability in animal cognitive studies.

• Warning Labels and Documentation
  All Unifiram products come labeled “Not for Human Consumption” and are accompanied by COA and SDS documentation where requested.

In research settings, Unifiram is often administered alongside other neuroactive compounds to explore potential synergistic effects, enhanced bioactivity, or complementary mechanisms. These combination studies are particularly useful in understanding how Unifiram interacts with racetams, cholinergics, and AMPAkines.

• Combination with Cholinergic Agents
  Researchers often study Unifiram with cholinergic precursors like CDP-Choline or Alpha-GPC to investigate enhanced acetylcholine signaling and its impact on memory and learning.

• Use with Racetams
  Although structurally distinct, Unifiram is frequently co-administered with racetams like Piracetam or Aniracetam to study overlapping effects on synaptic plasticity and to compare pharmacodynamic profiles.

• Co-administration with AMPAkines
  Since Unifiram modulates AMPA receptors indirectly, pairing it with direct AMPAkines like CX-516 or CX-546 may yield additive or synergistic effects, helping to map receptor specificity and downstream signaling.

• NMDA Antagonist Models
  Unifiram is sometimes used in models involving NMDA receptor antagonists (e.g., MK-801) to explore its ability to reverse glutamatergic dysfunction, which is relevant in schizophrenia and neurodegeneration studies.

• Neurotoxicity Attenuation
  In some studies, Unifiram has been paired with antioxidants or neuroprotective agents to assess its role in reducing oxidative stress and cellular toxicity under excitotoxic conditions.

• Behavioral Synergy
  Combination studies also look at behavioral changes in cognition, anxiety, and social interaction when Unifiram is co-administered with modulators of GABA, serotonin, or dopamine systems.

• Caution in Dosing
  Due to its extremely low active dose range, precise calibration is essential when combining Unifiram with other compounds to prevent unwanted pharmacological overlap or diminished efficacy.

Proper storage of Unifiram is critical to maintaining its chemical integrity, potency, and suitability for research. It is a highly sensitive compound that can degrade under conditions of heat, humidity, or light exposure.

• Recommended Temperature (Powder)
  The powdered form of Unifiram should be stored at –20°C in a tightly sealed container to maintain long-term stability.

• Storage for Solutions
  When dissolved in solvents like DMSO or ethanol, solutions should be aliquoted and kept at –80°C. Solutions are stable for up to 6 months under these conditions.

• Protection from Light and Humidity
  Unifiram should be stored in an amber vial or a light-resistant container, as prolonged light exposure can lead to photo-degradation. Moisture can also affect chemical purity, so desiccants are recommended.

• Minimize Freeze-Thaw Cycles
  For long-term preservation, divide your Unifiram into single-use aliquots. Repeated freeze-thawing may cause degradation or precipitation.

• Container Requirements
  Use airtight, chemically resistant containers (e.g., PTFE-lined screw caps) to avoid contamination or leaching, especially when storing in solution.

• Shelf Life (Powder)
  When stored correctly, Unifiram powder remains chemically stable for at least 24 months from the manufacturing date.

• Documentation for Quality Control
  Upon request, RC Plug provides batch-specific COA and SDS documentation, including storage guidelines, to support research traceability.

Solubility is a key factor in Unifiram research, especially for in vivo and in vitro applications. While it exhibits limited aqueous solubility, it dissolves effectively in several organic solvents suitable for research purposes.

• DMSO (Dimethyl Sulfoxide)
  DMSO is the most common solvent used for Unifiram, offering solubility up to ~30 mg/mL. It is ideal for preparing concentrated stock solutions for cell or animal studies.

• DMF (Dimethylformamide)
  DMF provides similar solubility to DMSO and is sometimes preferred due to slightly different polarity, which may influence bioavailability in certain assays.

• Ethanol
  Ethanol can dissolve Unifiram at low concentrations (up to ~1 mg/mL), suitable for specific applications but generally less efficient than DMSO or DMF.

• PEG (Polyethylene Glycol) Blends
  For in vivo delivery, researchers often dissolve Unifiram in PEG400 mixed with saline or water, offering a biocompatible vehicle that improves absorption.

• Tween-80/Formulation Agents
  When administering orally or intravenously in animal studies, solubility can be improved with surfactants like Tween-80 in small concentrations.

• pH Considerations
  While pH stability data is limited, it’s advised to avoid high-acid or high-alkaline buffers which may cause hydrolysis or chemical degradation.

• Filter Sterilization
  If required for cell culture, Unifiram solutions in solvents should be filter-sterilized using 0.2 μm PTFE filters to avoid microbial contamination.

Despite its cognitive-enhancing effects, Unifiram does not bind directly to AMPA receptors. Instead, it modulates their activity through indirect pathways, a mechanism that has made it a subject of interest in synaptic plasticity and excitatory signaling research.

• No Direct Receptor Binding
  Binding assays have confirmed that Unifiram does not directly attach to AMPA receptors, unlike some traditional AMPAkines.

• Allosteric Modulation Mechanism
  It likely acts via allosteric modulation, indirectly enhancing receptor response to endogenous glutamate, resulting in potentiated excitatory transmission.

• Facilitates Synaptic Potentiation
  The compound improves long-term potentiation (LTP) in hippocampal neurons, a key process underlying learning and memory formation.

• Signal Cascade Activation
  It may influence intracellular pathways, such as increased phosphorylation of AMPA subunits via protein kinase C (PKC), indirectly enhancing receptor conductance.

• Distinct from Traditional AMPAkines
  Unlike CX-series AMPAkines which bind at the receptor’s allosteric sites, Unifiram’s action is upstream and possibly involves neuromodulatory systems.

• Evidence from NBQX Models
  In animal studies, Unifiram counteracts memory deficits induced by NBQX (an AMPA receptor antagonist), reinforcing its role as a functional enhancer without direct binding.

Unifiram demonstrates a fast onset of action with effects lasting several hours in animal studies. However, exact pharmacokinetics remain largely unexplored due to the absence of human trials and limited metabolic profiling.

• Duration of Cognitive Effects
  Behavioral studies suggest Unifiram enhances cognitive performance for 2–4 hours post-administration, depending on the dose and route.

• Rapid Onset
  Observable improvements in learning tasks are often seen within 30 minutes of administration in rodent models, indicating fast absorption and bioavailability.

• Short Elimination Half-Life (Est.)
  Although exact half-life values are not published, the quick offset of effects and minimal residual activity suggest a relatively short half-life.

• No Sedation or Motor Interference
  Unlike sedatives or stimulants, Unifiram produces cognitive effects without altering locomotor activity, allowing clean behavioral testing during its active window.

• Suitable for Acute Studies
  Its temporal profile makes it ideal for single-dose experiments focused on memory retrieval, encoding, and acquisition phases.

• Unknown Metabolic Pathways
  Due to a lack of ADME (Absorption, Distribution, Metabolism, Excretion) studies, researchers should treat Unifiram as a short-acting compound until further data becomes available.

• Solvent Impact on Duration
  The chosen delivery solvent (e.g., DMSO vs. PEG) may influence Unifiram’s absorption rate and effective duration in live subjects.

Unifiram has primarily been tested in rodent models such as mice and rats. These species are commonly used in pharmacological studies to assess learning, memory, and neurochemical modulation. The compound’s efficacy in these models has contributed to its classification as one of the most potent experimental nootropics available for laboratory use.

• Rodents (Mice and Rats)
  The majority of published studies use mice (e.g., Swiss albino mice) and rats (e.g., Wistar rats) to evaluate Unifiram’s cognitive and behavioral effects.

• Passive Avoidance Tests
  Unifiram significantly enhances performance in step-down passive avoidance tasks, a standard model for evaluating long-term memory retention in rodents.

• Morris Water Maze
  Although less common, some exploratory studies suggest improved spatial memory in Unifiram-treated rats using maze navigation tests.

• Social Interaction Models
  In mice, Unifiram has been assessed for effects on social behavior, especially when combined with agents that induce deficits (e.g., NMDA antagonists).

• Pharmacologically Induced Amnesia Models
  Rodents pre-treated with amnestic agents like scopolamine or NBQX have shown recovery of learning ability when administered Unifiram.

• Motor Coordination Evaluation
  Tests like the rotarod show that Unifiram does not impair motor function, confirming its specificity for cognitive enhancement without sedation or ataxia.

• No Large Animal Data Available
  To date, there are no published studies involving Unifiram in primates, canines, or other higher-order species, which limits translational assumptions.

Unifiram has demonstrated the ability to reverse various types of experimentally induced memory deficits in animal models. This makes it a valuable research compound in the study of neurodegenerative diseases, cholinergic dysfunction, and glutamatergic imbalances.

• Reversal of Scopolamine-Induced Amnesia
  Unifiram effectively counteracts memory loss caused by scopolamine, a muscarinic receptor antagonist commonly used to model Alzheimer’s-like cognitive decline in animals.

• Counteracting NBQX-Induced Deficits
  NBQX, an AMPA receptor antagonist, induces deficits in learning and memory. Unifiram administration has been shown to restore normal cognitive function in such models, indicating its AMPA potentiation role.

• Efficacy Against Age-Related Impairment
  Preliminary studies suggest Unifiram may improve memory performance in aged rodents, pointing to its potential in age-associated cognitive decline research.

• Reversal of Diazepam-Induced Sedation
  In some behavioral tests, Unifiram mitigated the cognitive suppression induced by diazepam, without altering sedation levels, suggesting a non-GABAergic mechanism.

• Dose-Dependent Recovery
  Its memory-restorative effects occur in a narrow, dose-dependent range, making it suitable for precision pharmacology studies.

• Mechanistic Insight
  By enhancing synaptic plasticity and cholinergic transmission, Unifiram supports recovery of learning abilities across various deficit models.

• Neurotransmitter Interaction Studies
  These reversal effects are helpful in studying the cross-talk between neurotransmitter systems like acetylcholine and glutamate in memory function.

Unifiram’s toxicity profile remains largely unexplored due to its classification as a research chemical with no clinical trials. However, available animal data suggest a high margin of safety at effective doses, with no significant side effects observed in preclinical tests.

• No Human Toxicity Data
  There are no clinical studies evaluating toxicity, side effects, or long-term exposure outcomes in humans.

• High Safety Margin in Rodents
  Doses up to 1 mg/kg in rats and mice have not shown signs of toxicity or behavioral abnormalities, though comprehensive toxicology studies are lacking.

• No Observed Motor Impairment
  Rodents tested on rotarod and open field assays retained normal motor coordination, indicating that Unifiram does not cause sedation or ataxia.

• Organ Toxicity Not Reported
  There are no histological studies or biochemical assays that suggest hepatic, renal, or cardiovascular toxicity in animal models at experimental doses.

• Short-Term Exposure Focus
  Most safety data come from acute or subacute exposure studies; chronic toxicity, reproductive effects, or carcinogenicity remain uninvestigated.

• Caution Due to Lack of ADME Data
  Without data on Absorption, Distribution, Metabolism, and Excretion, researchers should exercise caution in designing long-term or high-dose studies.

• Strict Laboratory Use Only
  All handling of Unifiram must follow institutional safety protocols, including use of gloves, fume hoods, and protective equipment.

To support responsible and compliant research use, RC Plug provides full technical documentation with every Unifiram purchase upon request. This includes lab-grade material verification, purity confirmation, and handling instructions.

• Certificate of Analysis (COA)
  Each batch is accompanied by a COA that confirms compound identity, purity (≥98%), and analytical method used (typically HPLC).

• Safety Data Sheet (SDS)
  The SDS outlines proper handling, storage, hazard identification, and first-aid procedures, ensuring lab compliance with chemical safety standards.

• Batch and Lot Numbers
  Every shipment is traceable through unique batch or lot numbers printed on the packaging and documentation.

• Storage and Stability Guidelines
  Documentation includes detailed instructions for proper storage temperature, solvent compatibility, and degradation risks.

• Non-Human Use Labeling
  All Unifiram packaging is clearly marked “Not for Human Consumption” to ensure compliance with legal and institutional requirements.

• Regulatory Classification Notes
  Information on Unifiram’s status in major jurisdictions (e.g., not scheduled in the U.S., EU) is provided for import/export review.

• Request Process
  COA and SDS can be downloaded after purchase, or included physically in the package if requested during checkout.

We prioritize efficient order fulfillment and global reach. Our shipping system is optimized to deliver Unifiram safely, quickly, and discreetly, regardless of your location. Every order is processed promptly and includes tracking information for real-time monitoring.

• 24–48 Hour Processing Time
  Orders are typically processed and dispatched within one to two business days after payment confirmation.

• Same-Day Shipping for Select Orders
  For high-priority or overnight shipments, same-day dispatch is available if payment clears before our cutoff time.

• Overnight Shipping Options
  We offer overnight delivery within eligible regions using premium courier services, ensuring time-sensitive orders are fulfilled promptly.

• Discreet, Unmarked Packaging
  All items are packed in unbranded envelopes or boxes with tamper-evident seals to maintain privacy and prevent seizure during transit.

• Tracking Provided Immediately
  A unique tracking number is issued and sent via email upon shipment so you can follow your order every step of the way.

• International Shipping Available
  We ship globally, and our support team is experienced in navigating customs requirements for research chemicals.

• Customer Support for Delays
  Our support team is always available to assist with tracking issues, customs clearance, or lost parcel claims.

At RC Plug, we prioritize your satisfaction and peace of mind. Although all our Unifiram batches are lab-verified and handled under strict quality control, we understand that research expectations may vary. That’s why we back every purchase with a risk-free return or replacement policy.

• 30-Day Refund or Replacement Guarantee
  If you’re not satisfied with the Unifiram you received, you can request a full refund or a replacement product within 30 days of delivery.

• No Questions Asked Policy
  We honor refund or replacement requests without requiring a detailed explanation, provided the product is returned unopened and in original condition.

• Defective or Damaged Orders
  If your shipment is damaged in transit or the product is compromised, we will replace it immediately at no additional cost.

• Return Instructions Provided
  Our customer service team will guide you through the return process, including packaging, return address, and refund timeline.

• Fast Refund Processing
  Once your return is received and inspected, refunds are typically processed within 3–5 business days.

• Eligibility Requirements
  Products must be returned in their original sealed state. Opened or used chemicals are not eligible due to safety and contamination risks.

• Support Contact Availability
  Our support team is available to assist with any concerns, helping ensure you are fully supported through the entire process.